Mitsuhiro Ibe
President chez ZERIA PHARMACEUTICAL CO., LTD.
Fortune : 1 M $ au 31/03/2024
Postes actifs de Mitsuhiro Ibe
Sociétés | Poste | Début | Fin |
---|---|---|---|
ZERIA PHARMACEUTICAL CO., LTD. | Chief Operating Officer | 01/06/2014 | - |
Director/Board Member | 01/06/2010 | - | |
President | 01/06/2014 | - | |
Comptroller/Controller/Auditor | 01/04/2010 | 01/04/2011 | |
Sales & Marketing | 01/04/2011 | 01/06/2011 | |
Tillotts Pharma AG
Tillotts Pharma AG Pharmaceuticals: MajorHealth Technology Tillotts Pharma AG manufactures pharmaceuticals for treatment of gastrointestinal diseases. The firm specializes in the therapy of the lower gastrointestinal tract. It offers Asacol, Entocort, Colpermin, Tillhepo and VistaPrep. The company was founded in 1986 and is headquartered in Ziefen, Switzerland. | Director/Board Member | - | - |
Historique de carrière de Mitsuhiro Ibe
Statistiques
Internationale
Suisse | 2 |
2 |
Opérationnelle
Director/Board Member | 2 |
Comptroller/Controller/Auditor | 1 |
Chief Operating Officer | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Tillotts Pharma AG
Tillotts Pharma AG Pharmaceuticals: MajorHealth Technology Tillotts Pharma AG manufactures pharmaceuticals for treatment of gastrointestinal diseases. The firm specializes in the therapy of the lower gastrointestinal tract. It offers Asacol, Entocort, Colpermin, Tillhepo and VistaPrep. The company was founded in 1986 and is headquartered in Ziefen, Switzerland. | Health Technology |
Zeria Pharmaceutical Co., Ltd. |
- Bourse
- Insiders
- Mitsuhiro Ibe
- Expérience